Cargando…
A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder
BACKGROUND: Evidence is accumulating that Cognitive Remediation Training (CRT) is effective for ameliorating cognitive deficits experienced by patients with schizophrenia and accompanying functional impairment. There has been no randomized controlled trial of CRT using a nationally representative po...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334394/ https://www.ncbi.nlm.nih.gov/pubmed/30646884 http://dx.doi.org/10.1186/s12888-019-2018-6 |
_version_ | 1783387704554160128 |
---|---|
author | O’Reilly, Ken Donohoe, Gary O’Sullivan, Danny Coyle, Ciaran Corvin, Aiden O’Flynn, Padraic O’Donnell, Muireann Galligan, Toni O’Connell, Paul Kennedy, Harry G. |
author_facet | O’Reilly, Ken Donohoe, Gary O’Sullivan, Danny Coyle, Ciaran Corvin, Aiden O’Flynn, Padraic O’Donnell, Muireann Galligan, Toni O’Connell, Paul Kennedy, Harry G. |
author_sort | O’Reilly, Ken |
collection | PubMed |
description | BACKGROUND: Evidence is accumulating that Cognitive Remediation Training (CRT) is effective for ameliorating cognitive deficits experienced by patients with schizophrenia and accompanying functional impairment. There has been no randomized controlled trial of CRT using a nationally representative population of forensic patients, despite the significant cognitive deficits frequently present within this group. METHODS: Sixty-five patients with schizophrenia or schizoaffective disorder were enrolled in a single blind randomized controlled trial of CRT versus treatment as usual (TAU); representing 94% of those eligible within a national forensic cohort. The primary outcome measure was the composite score of the MATRICS Consensus Cognitive Battery (MCCB). Secondary outcome measures included neurocognitive and social cognitive domains, symptoms, and ‘real world’ functioning. Patient satisfaction was examined using an exit interview. Participants were reassessed at 8 months follow up. All data were analyzed using an intention to treat design (ITT). RESULTS: For the primary outcome measure, the MCCB composite score, there were significant differences between those who participated in CRT and those receiving TAU at both end of treatment and 8 months follow up (Cohen’s d = 0.34. Significant improvements were observed in visual and working memory. Mediation analysis found that those who cognitively benefited from CRT had corresponding improved functioning, and more net positive therapeutic moves i.e. moves to units with lower security within the hospital. Ninety-six percent believed their cognitive gains positively affected their daily lives. CONCLUSIONS: CRT may be an acceptable and efficacious intervention for forensic patients with schizophrenia or schizoaffective disorder. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02360813. Trial registered Feb 4th 2015, last updated May 1st 2015. |
format | Online Article Text |
id | pubmed-6334394 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63343942019-01-23 A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder O’Reilly, Ken Donohoe, Gary O’Sullivan, Danny Coyle, Ciaran Corvin, Aiden O’Flynn, Padraic O’Donnell, Muireann Galligan, Toni O’Connell, Paul Kennedy, Harry G. BMC Psychiatry Research Article BACKGROUND: Evidence is accumulating that Cognitive Remediation Training (CRT) is effective for ameliorating cognitive deficits experienced by patients with schizophrenia and accompanying functional impairment. There has been no randomized controlled trial of CRT using a nationally representative population of forensic patients, despite the significant cognitive deficits frequently present within this group. METHODS: Sixty-five patients with schizophrenia or schizoaffective disorder were enrolled in a single blind randomized controlled trial of CRT versus treatment as usual (TAU); representing 94% of those eligible within a national forensic cohort. The primary outcome measure was the composite score of the MATRICS Consensus Cognitive Battery (MCCB). Secondary outcome measures included neurocognitive and social cognitive domains, symptoms, and ‘real world’ functioning. Patient satisfaction was examined using an exit interview. Participants were reassessed at 8 months follow up. All data were analyzed using an intention to treat design (ITT). RESULTS: For the primary outcome measure, the MCCB composite score, there were significant differences between those who participated in CRT and those receiving TAU at both end of treatment and 8 months follow up (Cohen’s d = 0.34. Significant improvements were observed in visual and working memory. Mediation analysis found that those who cognitively benefited from CRT had corresponding improved functioning, and more net positive therapeutic moves i.e. moves to units with lower security within the hospital. Ninety-six percent believed their cognitive gains positively affected their daily lives. CONCLUSIONS: CRT may be an acceptable and efficacious intervention for forensic patients with schizophrenia or schizoaffective disorder. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02360813. Trial registered Feb 4th 2015, last updated May 1st 2015. BioMed Central 2019-01-15 /pmc/articles/PMC6334394/ /pubmed/30646884 http://dx.doi.org/10.1186/s12888-019-2018-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article O’Reilly, Ken Donohoe, Gary O’Sullivan, Danny Coyle, Ciaran Corvin, Aiden O’Flynn, Padraic O’Donnell, Muireann Galligan, Toni O’Connell, Paul Kennedy, Harry G. A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder |
title | A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder |
title_full | A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder |
title_fullStr | A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder |
title_full_unstemmed | A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder |
title_short | A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder |
title_sort | randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334394/ https://www.ncbi.nlm.nih.gov/pubmed/30646884 http://dx.doi.org/10.1186/s12888-019-2018-6 |
work_keys_str_mv | AT oreillyken arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT donohoegary arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT osullivandanny arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT coyleciaran arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT corvinaiden arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT oflynnpadraic arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT odonnellmuireann arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT galligantoni arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT oconnellpaul arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT kennedyharryg arandomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT oreillyken randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT donohoegary randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT osullivandanny randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT coyleciaran randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT corvinaiden randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT oflynnpadraic randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT odonnellmuireann randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT galligantoni randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT oconnellpaul randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder AT kennedyharryg randomizedcontrolledtrialofcognitiveremediationforanationalcohortofforensicpatientswithschizophreniaorschizoaffectivedisorder |